Clinical Trial Update: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of triheptanoin in Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Adrian Lacy | Conditions: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28